La enfermedad renal terminal asociada con diabetes en las Islas Canarias: Un problema de salud pública, de elevado sufrimiento humano y alto coste económico

Nefrologia

Volumn 30, Issue 4, 2010, Pages 381-384

  Lorenzo, V ^a   Boronat, M ^b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; COST OF ILLNESS; DIABETES MELLITUS; ECONOMICS; EDITORIAL; HUMAN; PUBLIC HEALTH; SPAIN;

COST OF ILLNESS; DIABETES COMPLICATIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PUBLIC HEALTH; SPAIN;

EID: 77956029683     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Jun.10455     Document Type: Editorial

References (25)

1. Lorenzo V, Martín Urcuyo B. Análisis epidemiológico del incremento de insuficiencia renal terminal asociada a diabetes mellitus tipo 2. Nefrologia 2000;20:77-81.[Pubmed]
2. Lorenzo V, Sánchez E, Vega N, Hernández D. Renal replacement therapy in the Canary Islands: demographic and survival analysis. J Nephrol 2006;19:97-103.[Pubmed]
3. Ceballos M, López-Revuelta K, Saracho R, et al. Informe de diálisis y trasplante correspondiente al año 2002 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia 2005;25:121-9.[Pubmed]
4. López RK, Saracho R, García LF, et al. Informe de diálisis y trasplante año 2001 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia 2004;24:21-33.[Pubmed]
5. De Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F, et al. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population-comparison of the 1997 ADA and the 1985 WHO criteria. The Guia Study. Diabet Med 2001;18:235-41.[Pubmed]
6. Martínez-Castelao A, De Álvaro F, Górriz JL. Epidemiology of diabetic nephropathy in Spain. Kidney Int 2005;Suppl:S20-S24.
7. Boronat M, Varillas VF, Saavedra P, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2006;23:148-55.[Pubmed]
8. Cabrera de León A, Rodríguez-Pérez MC, Del Castillo-Rodríguez JC, et al. Estimación del riesgo coronario en la población de Canarias aplicando la ecuación de Framingham. Med Clin (Barc) 2006;126:521-6.[Pubmed]
9. Ministerio de Sanidad y Consumo. Health Statistics. Encuesta Nacional de Salud, 2009. Availabe at: http://www.msc.es/en/estadEstudios/estadisticas/encuestaNacional/home.ht m
10. Lorenzo V, Boronat M, Saavedra P, et al. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk. Nephrol Dial Transplant. Advance Access published on January 11, 2010. doi:10.1093/ndt/gfp761
11. Villar AF, Banegas B Jr., Rodríguez AF, Del Rey CJ. Mortalidad cardiovascular en España y sus Comunidades Autónomas (1975-1992). Med Clin (Barc) 1998;110:321-7.[Pubmed]
12. Goday A. Epidemiología de la diabetes y sus complicaciones no coronarias. Rev Esp Cardiol 2002;55:657-70.[Pubmed]
13. Maca-Meyer N, Arnay M, Rando JC, et al. Ancient mtDNA analysis and the origin of the Guanches. Eur J Hum Genet 2004;12:155-62.[Pubmed]
14. Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005;67:1684-91.[Pubmed]
15. Bruce MA, Beech BM, Crook ED, et al. Association of Socioeconomic Status and CKD Among African Americans: The Jackson Heart Study. Am J Kidney Dis 2010.
16. Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008;19:1261-70.[Pubmed]
17. Aranceta J, Pérez RC, Serra ML, et al. Prevalencia de obesidad en España: resultados del estudio SEEDO 2000. Med Clin (Barc) 2003;120:608-12.[Pubmed]
18. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008;51:563-72.[Pubmed]
19. Navarro López V, Benach de Rovira J. Social inequities of health in Spain. Report of the Scientific Commission for the Study of Social Inequities in Health in Spain. Rev Esp Salud Publica 1996;70:505-36.[Pubmed]
20. Gutiérrez-Fisac JL, Rodríguez AF, Guallar-Castillón P, et al. Determinants of geographical variations in body mass index (BMI) and obesity in Spain. Int J Obes Relat Metab Disord 1999;23:342-7.[Pubmed]
21. Lorenzo V, Perestelo I, Barroso M, Torres A, Nazco J. Evaluación económica de la hemodiálisis. Análisis de los componentes del coste basado en datos individuales. Nefrologia 2010;30(4):403-12.
22. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999;353:617-22.[Pubmed]
23. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93. [Pubmed]
24. Postma MJ, De ZD. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2009;24:2975-83.[Pubmed]
25. Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis 2006;3:A57.[Pubmed]